# Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program

> **NCT00096811** · — · NO_LONGER_AVAILABLE · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Hepatitis B
- Chronic Disease

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT00096811
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** 2003-09
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** — (—)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096811, "Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00096811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*